test

Sean Tan

@Stempoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$334.017MTotal holdings50
Assets growth rate-1.84%Assets growth rate (2-Q avg)-5.94%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 50 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 334.017M in assets, with a quarterly growth rate of -1.84% and a 2-quarter average growth rate of -5.94%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 38.88%
10.1%
$33.707M
1.961M shares@ $17.19 avg price
ROIVRoivant Sciences Ltd
Recent Activity
Increased 2.11%
9.57%
$31.964M
2.77M shares@ $11.54 avg price
MRUSMerus N V
Recent Activity
Increased 45.92%
6.31%
$21.044M
421,222 shares@ $49.96 avg price
IMVTImmunovant Inc
Recent Activity
Decreased -13.92%
5.77%
$19.243M
871,001 shares@ $22.1 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Increased 38.42%
4.96%
$16.551M
2.028M shares@ $8.16 avg price
FOLDAmicus Therapeutics Inc
Recent Activity
Decreased -0.88%
4.74%
$15.826M
1.482M shares@ $10.68 avg price
BMYBristol-myers Squibb Co
Recent Activity
New Position
4.27%
$14.244M
275,303 shares@ $51.74 avg price
APLTApplied Therapeutics Inc
Recent Activity
Decreased -18.32%
3.98%
$13.289M
1.806M shares@ $7.36 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Decreased -61.2%
3.28%
$10.926M
213,815 shares@ $51.11 avg price
BHVNBiohaven Ltd
Recent Activity
Decreased -7.2%
3.24%
$10.816M
216,440 shares@ $49.98 avg price